Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
– Sell
-3,600
Closed -$205K – 1154
2017
Q3
$205K Buy
+3,600
New +$208K ﹤0.01% 1060
2016
Q4
– Sell
-20,000
Closed -$1.07M – 1576
2016
Q3
$1.07M Buy
+20,000
New +$1.09M 0.01% 1060
2016
Q1
– Sell
-60,000
Closed -$2.82M – 1494
2015
Q4
$2.82M Hold
60,000
– – 0.01% 632
2015
Q3
$2.9M Hold
60,000
– – 0.02% 632
2015
Q2
$2.97M Buy
60,000
+40,000
+200% +$2.12M 0.02% 660
2015
Q1
$1.09M Hold
20,000
– – 0.01% 1128
2014
Q4
$1.11M Sell
20,000
-10,000
-33% -$545K 0.01% 1133
2014
Q3
$1.58M Buy
+30,000
New +$1.55M 0.01% 922
2014
Q2
– Sell
-40,000
Closed -$1.94M – 1646
2014
Q1
$1.94M Buy
+40,000
New +$1.86M 0.01% 817
2013
Q4
– Sell
-20,000
Closed -$5.99M – 1621
2013
Q3
$5.99M Buy
+20,000
New +$849K 0.04% 483

Other funds holding SRE

Nuveen's SRE Position: Q2 2026 in Review

Nuveen reduced its Sempra (SRE) stake by 21% in Q2 2026, selling an estimated $53.8M and leaving 2,202,117 shares worth $204M. The position accounts for 0.05% of the portfolio, ranked #274.

Nuveen first reported a position in SRE in Q2 2013 and has held it in 52 quarters since. The position peaked at $377M in Q2 2019. 1,289 funds tracked by Wall St. Rank hold SRE as of Q2 2026.

  • Nuveen held 2,202,117 shares of Sempra worth $204M as of Q2 2026.
  • Nuveen sold 578,432 Sempra shares in Q2 2026, an estimated $53.8M.
  • Sempra made up 0.05% of Nuveen's portfolio in Q2 2026, its #274 holding.
  • Nuveen first reported a position in Sempra in Q2 2013 and has held it in 52 quarters since.
  • Nuveen's Sempra position peaked at $377M in Q2 2019.
  • 1,289 funds tracked by Wall St. Rank held Sempra as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.